Related references
Note: Only part of the references are listed.New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction
Yumi Tsuneura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Regulation of Reelin functions by specific proteolytic processing in the brain
Mitsuharu Hattori et al.
JOURNAL OF BIOCHEMISTRY (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Analysis of Reelin signaling and neurodevelopmental trajectory in primary cultured cortical neurons with RELN deletion identified in schizophrenia
Yumi Tsuneura et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6
Janice M. Ranson et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Advances in Genetics and Epigenetic Alterations in Alzheimer's Disease: A Notion for Therapeutic Treatment
Ruben Rabaneda-Bueno et al.
GENES (2021)
APOE Genotype and Alzheimer's Disease: The Influence of Lifestyle and Environmental Factors
Efthalia Angelopoulou et al.
ACS CHEMICAL NEUROSCIENCE (2021)
The structure-function relationship of a signaling-competent, dimeric Reelin fragment
Liam S. Turk et al.
STRUCTURE (2021)
Apolipoprotein E promotes white matter remodeling via the Dab1-dependent pathway after traumatic brain injury
Zhi-Jian Huang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Development and Maturation
Yves Jossin
BIOMOLECULES (2020)
Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease
Charis Ringland et al.
NEUROBIOLOGY OF AGING (2020)
CSF-ApoER2 fragments as a read-out of reelin signaling: Distinct patterns in sporadic and autosomal-dominant Alzheimer disease
Inmaculada Lopez-Font et al.
CLINICA CHIMICA ACTA (2019)
Proteases Upregulation in Sporadic Alzheimer's Disease Brain
Alessandro Medoro et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microscopy
Paula Dlugosz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease
Christopher D. Whelan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications
Francesco Angelucci et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease
Na Zhao et al.
BIOLOGICAL PSYCHIATRY (2018)
Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease
Trinidad Mata-Balaguer et al.
FASEB JOURNAL (2018)
Reversal of ApoE4-induced recycling block as a novel prevention a proach for Alzheimer's disease
Xunde Xian et al.
ELIFE (2018)
The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease
Courtney Lane-Donovan et al.
JOURNAL OF LIPID RESEARCH (2017)
Secreted Metalloproteinase ADAMTS-3 Inactivates Reelin
Himari Ogino et al.
JOURNAL OF NEUROSCIENCE (2017)
Presenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2
Wei Wang et al.
NEUROBIOLOGY OF AGING (2017)
Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs
Rajnish Kumar et al.
BRAIN (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less
Inmaculada Cuchillo-Ibanez et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer's disease
Aitana Sogorb-Esteve et al.
MOLECULAR NEURODEGENERATION (2016)
ANALYSIS OF GENETICS AND RISK FACTORS OF ALZHEIMER'S DISEASE
M. Panpalli Ates et al.
NEUROSCIENCE (2016)
The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease
Inmaculada Cuchillo-Ibanez et al.
SCIENTIFIC REPORTS (2016)
Importance of Reelin C-Terminal Region in the Development and Maintenance of the Postnatal Cerebral Cortex and Its Regulation by Specific Proteolysis
Takao Kohno et al.
JOURNAL OF NEUROSCIENCE (2015)
Reelin protects against amyloid β toxicity in vivo
Courtney Lane-Donovan et al.
SCIENCE SIGNALING (2015)
Reelin protects against amyloid β toxicity in vivo
Courtney Lane-Donovan et al.
SCIENCE SIGNALING (2015)
ApoER2 processing by presenilin-1 modulates reelin expression
Valeria Balmaceda et al.
FASEB JOURNAL (2014)
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid
Cecilia E. Hanzel et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Ligand-induced Homotypic and Heterotypic Clustering of Apolipoprotein E Receptor 2
Shailaja D. Divekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
Leon M. Tai et al.
MOLECULAR NEURODEGENERATION (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease
Lluis Pujadas et al.
NATURE COMMUNICATIONS (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
Beta-Amyloid Impairs Reelin Signaling
Inmaculada Cuchillo-Ibanez et al.
PLOS ONE (2013)
CSF Presenilin-1 complexes are increased in Alzheimer's disease
Maria-Salud Garcia-Ayllon et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) cleaves Reelin in an isoform-dependent manner
Arisa Hisanaga et al.
FEBS LETTERS (2012)
Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology
Arne Herring et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The Metalloprotease Meprin β Generates Amino Terminal-truncated Amyloid β Peptide Species
Jessica Bien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
David M. Holtzman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo
Tamara Jefferson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Functional Importance of Covalent Homodimer of Reelin Protein Linked via Its Central Region
Norihisa Yasui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density
Justin T. Rogers et al.
LEARNING & MEMORY (2011)
β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
Arancha Botella-Lopez et al.
NEUROBIOLOGY OF DISEASE (2010)
ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
Ying Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The N-terminal fragment of Reelin is generated after endocytosis and released through the pathway regulated by Rab11
Terumasa Hibi et al.
FEBS LETTERS (2009)
Reelin signaling antagonizes β-amyloid at the synapse
Murat S. Durakoglugil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis
Hyang-Sook Hoe et al.
JOURNAL OF NEUROSCIENCE (2007)
Processing of reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons
Yves Jossin et al.
JOURNAL OF NEUROSCIENCE (2007)
Apolipoprotein receptor 2 and X11 α/β mediate apolipoprotein E-induced endocytosis of amyloid-β precursor protein and β-secretase, leading to amyloid-β production
Xiangyuan He et al.
JOURNAL OF NEUROSCIENCE (2007)
Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease
Jeannie Chin et al.
JOURNAL OF NEUROSCIENCE (2007)
Reelin expression and glycosylation patterns are altered in Alzheimer's disease
A Botella-López et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2
U Beffert et al.
NEURON (2005)
Characterization of the various forms of the Reelin protein in the cerebrospinal fluid of normal subjects and in neurological diseases
N Ignatova et al.
NEUROBIOLOGY OF DISEASE (2004)
Receptor clustering is involved in reelin signaling
V Strasser et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Reelin and brain development
F Tissir et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease
J Sáez-Valero et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling
S Koch et al.
EMBO JOURNAL (2002)
Secreted Reelin molecules form homodimers
K Kubo et al.
NEUROSCIENCE RESEARCH (2002)
Reelin in plaques of β-amyloid precursor protein and presenilin-1 double-transgenic mice
O Wirths et al.
NEUROSCIENCE LETTERS (2001)
Multiplex detection and quantitation of proteins on Western blots using fluorescent probes
JC Gingrich et al.
BIOTECHNIQUES (2000)
Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells
NR Smalheiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
No association between the alpha 2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
K Blennow et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
